表紙:肥満治療の米国市場:Medtech 360
市場調査レポート
商品コード
1745940

肥満治療の米国市場:Medtech 360

Obesity Interventions | Medtech 360 | Market Insights | United States


出版日
発行
Clarivate
ページ情報
英文
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
肥満治療の米国市場:Medtech 360
出版日: 2025年06月06日
発行: Clarivate
ページ情報: 英文
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

GLP-1受容体作動薬の台頭は、肥満治療の情勢を大きく変え、肥満治療の成長に影響を与え、機器の売上にも影響を及ぼしています。GLP-1分野における技術革新と将来の償還は、肥満治療の需要に下方圧力をかけ続けると予測されます。このような状況にもかかわらず、肥満人口の拡大と治療率の増加が肥満治療市場を牽引すると予測されます。さらに、より侵襲性の低い内腔治療と、より高い価格を要求する革新的技術の採用が、肥満治療市場の維持に寄与するとみられます。

GLP-1受容体作動薬は近年、米国の患者集団の間で採用が急増しています。

ロボット支援肥満治療が肥満治療市場全体を支えます。

米国の医師の間では、減量に向けて新しい肥満治療を採用する動向が高まっています。

予測期間に新たな競合がこの分野に参入してくる見込みです。

当レポートでは、米国の肥満治療市場について調査分析し、2019年~2034年の市況に関する包括的なデータと分析を提供しています。

目次

米国

要約

エグゼクティブサマリー

  • COVID-19の最新情報
  • 市場のハイライト
  • 競合のハイライト
  • 市場の発展
  • 対象となる治療
  • 対象となる製品

主なレポートの更新

肥満治療市場

  • 市場のハイライト
    • 主なコンテンツの更新
  • 市場の定義
  • 疫学予測データ
  • 治療予測データ
  • 市場予測データ
  • 市場シェア
  • 競合考察
    • Medtronic
    • Johnson & Johnson Medtech
    • Boston Scientific
    • ReShape Lifesciences
    • その他の主な競合
    • すべての競合に影響を与える要因
  • 市場の発展

胃バンド市場

  • 市場のハイライト
    • 主なコンテンツの更新
  • 市場の定義
  • 市場予測データ
  • 市場シェア
  • 競合考察
    • 米国の胃バンドの競合考察

内部閉鎖機器市場

  • 市場のハイライト
    • 主なコンテンツの更新
  • 市場の定義
  • 市場予測データ
  • 市場シェア
  • 競合考察
    • 米国の内部閉鎖機器の競合考察

胃内バルーン市場

  • 市場のハイライト
    • 主なコンテンツの更新
  • 市場の定義
  • 市場予測データ
  • 市場シェア
  • 競合考察
    • 米国の胃内バルーンの競合考察
    • すべての競合に影響を与える要因

付録

調査手法

目次

The rise of GLP-1 receptor agonists is significantly transforming the landscape of obesity treatment, impacting the growth of bariatric procedures and affecting device sales. Innovations and future reimbursements in the GLP-1 space are expected to continue placing downward pressure on the demand for bariatric procedures. Despite this, the growing obese population and increased treatment rates are anticipated to drive the obesity intervention market. Additionally, less-invasive endoluminal procedures and the adoption of innovative technologies that command higher prices will contribute to sustaining the obesity intervention market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the obesity intervention market in the US from 2019 through 2034.

GLP-1 receptor agonists have been experiencing a meteoric rise in adoption among the US patient population in recent years.

  • How has the rise in GLP-1 receptor agonist prescriptions affected the obesity intervention market?
  • Will the obesity intervention market recover from the increasing use of GLP-1 receptor agonists?
  • Considering the emerging pharmacological therapies in the pipeline, what is the long-term outlook for bariatric surgery procedures?
  • Can there be a complementary use of GLP-1 receptor agonists and bariatric surgery?
  • What strategies can competitors within the obesity intervention market employ to adapt to the increasing use of GLP-1 receptor agonists?

Robotic-assisted bariatric procedures will support the overall obesity intervention market.

  • Which procedure types have the highest and lowest laparoscopic technique penetration amid the growing influence of robotic surgery?
  • Given the rise of robotic surgery, which laparoscopic bariatric procedures are still growing, and which ones are nearing saturation?
  • Which technique-open or laparoscopic-is more affected by the rise of robotic surgery?

There is a growing trend among US physicians to adopt novel bariatric procedures for weight loss.

  • What are these new procedures?
  • What will be the expected growth rate of these procedures over the forecast period?

New competitors are expected to enter this space within the forecast period.

  • Who are these competitors and what products are they bringing to the market?
  • Which segments are seeing the most incoming competitors?

Table of Contents

United States

Abstract

Executive Summary

  • COVID-19 Updates
  • Market Highlights
  • Competitive Highlights
  • Market Developments
  • Procedures Covered
  • Products Covered

Key Report Updates

Obesity Intervention Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Epidemiology Forecast Data
  • Procedure Forecast Data
  • Market Forecast Data
  • Market Shares
  • Competitive Insights
    • Medtronic
    • Johnson & Johnson Medtech
    • Boston Scientific
    • ReShape Lifesciences
    • Other Key Competitors
    • Factors Affecting All Competitors
  • Market Developments

Gastric Band Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Market Forecast Data
  • Market Shares
  • Competitive Insights
    • US Gastric Band Competitive Insights

Internal Closure Device Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Market Forecast Data
  • Market Shares
  • Competitive Insights
    • US Internal Closure Device Competitive Insights

Intragastric Balloon Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Market Forecast Data
  • Market Shares
  • Competitive Insights
    • US Intragastric Balloon Competitive Insights
    • Factors Affecting All Competitors

Appendix

  • Abbreviations
  • Bibliography

Methodology

  • Core Country Coverage Methodology
  • Research Methodology
  • Marketrack Methodology
  • PriceTrack Methodology
  • Forecast Methodology
  • Supplemental Country Coverage Methodology
  • Base-Year Ratio Analysis
  • Market Forecasting

Tables and figures

  • Obesity Intervention Market, by Product Type, US (USD), 2019-2034
  • Obesity Intervention Market Landscape, US (USD), 2024 and 2034
  • Obesity Intervention Revenue Market Share Rankings, by Product Type, US, 2024
  • Competitive Insights
  • Companies Mentioned
  • Recent Events in the Obesity Intervention Market, US
  • Key Clinical Trials in the Obesity Intervention Market, US
  • Emerging Products for the Obesity Intervention Market, US
  • Obesity Intervention Procedures Covered, US
  • Obesity Intervention Devices Covered, US
  • US Obesity Intervention Market Drivers
  • US Obesity Intervention Market Limiters
  • Obesity Intervention Market, by Product Type, US (USD), 2019-2034
  • Obesity, Total Prevalence, by Class and Gender, US, 2019, 2027, and 2034
  • Obesity, Total Prevalence, by Class and Gender, as a % of Total, US, 2019, 2027, and 2034
  • Overweight, Total Prevalence, by Gender, US, 2019, 2027, and 2034
  • Obesity Intervention Procedures, by Procedure Type, US, 2019-2034
  • Bariatric Procedures, by Procedure Type, US, 2019-2034
  • Endoluminal Procedures, by Procedure Type, US, 2019-2034
  • Gastric Banding Procedures, by Technique, US, 2019-2034
  • Gastric Banding Procedures, by Treatment Type, US, 2019-2034
  • Sleeve Gastrectomies, by Technique, US, 2019-2034
  • Sleeve Gastrectomies, by Treatment Type, US, 2019-2034
  • Gastric Bypass Procedures, by Technique, US, 2019-2034
  • Gastric Bypass Procedures, by Treatment Type, US, 2019-2034
  • BPD Procedures, by Technique, US, 2019-2034
  • Single-Anastomosis Duodenal-Ileal Bypass with Sleeve procedures, by Technique, US, 2019-2034
  • One-Anastomosis Gastric Bypass procedures, by Technique, US, 2019-2034
  • Obesity Intervention Market, by Product Type, US (USD), 2019-2034
  • Obesity Intervention Market Growth, by Product Type, US, 2020-2034
  • Obesity Intervention Revenue Market Shares, US, 2024
  • Obesity Intervention Revenue Market Shares, by Product Type, US, 2024
  • Medtronic Competitive Insights
  • Johnson & Johnson Medtech Competitive Insights
  • Boston Scientific Competitive Insights
  • ReShape Lifesciences Competitive Insights
  • Competitive Insights for Other Key Competitors
  • Recent Events in the Obesity Intervention Market, US
  • Key Clinical Trials in the Obesity Intervention Market, US
  • Emerging Products for the Obesity Intervention Market, US
  • US Gastric Band Market Limiters
  • Gastric Band Market, US (USD), 2019-2034
  • Gastric Band Market, US (USD), 2019-2034
  • Gastric Band Revenue Market Shares, US, 2024
  • Gastric Band Revenue Market Shares, US, 2024
  • US Internal Closure Device Market Drivers
  • US Internal Closure Device Market Limiters
  • Internal Closure Device Market, by Product Type, US (USD), 2019-2034
  • Internal Closure Device Market, by Product Type, US (USD), 2019-2034
  • Internal Closure Device Market Growth, by Product Type, US, 2020-2034
  • Internal Closure Device Revenue Market Shares, US, 2024
  • Internal Closure Device Revenue Market Shares, by Product Type, US, 2024
  • Buttressing Device Revenue Market Shares Rankings, US, 2024
  • US Intragastric Balloon Market Drivers
  • US Intragastric Balloon Market Limiters
  • Intragastric Balloon Market, US (USD), 2019-2034
  • Intragastric Balloon Market, US (USD), 2019-2034
  • Intragastric Balloon Revenue Market Shares, US, 2024
  • Intragastric Balloon Revenue Market Shares, US, 2024